Delivery Order SPE2DR25D3103-SPE2DR26F9K36
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,512.96 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on a firm fixed-price basis. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-competitive delivery order under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Procainamide 1 gram/10 mL vials totaling $1,539.32 on September 4, 2025, with completion due by September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,505.03. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Department's Medical Supply Chain for one gram per 10 milliliter vials of Procainamide, a cardiac antiarrhythmic medication. The May 30, 2025 award, valued at $1,562.92 with completion scheduled for June 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,968.88 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract covers the supply of Procainamide 1 gram/10 milliliter vials (10 milliliter quantity), an antiarrhythmic medication used in cardiac care. This is a firm fixed-price delivery order with no set-aside designation, awarded through open...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for procurement of Procainamide 1 gram/10 milliliter vials with a ceiling value of $5,235.21. This firm fixed price delivery order was awarded on May 20, 2025, with an ultimate completion date of May 21, 2025, and represents a non-competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $3,164.53. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Procainamide 1,000 mg/2 ml vials with a ceiling value of $10,193.42 under a firm fixed-price arrangement. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 pharmaceutical prime vendor agreement running through December 2026. The contract requires performance...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9K36Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $12.5K delivery order on December 1, 2025, for the supply of Procainamide 1 gram/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical federal vendor supplying a broad range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements through open competition. Procainamide is an antiarrhythmic medication used in cardiac care, reflecting the types of specialty pharmaceuticals the contractor routinely delivers to support Defense Health Agency and other federal healthcare customers through its DLA prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 11/30/25 |